RNA Therapeutics

siRNA
#Financing #Oligonucleotide therapeutics #Ractigen Therapeutics #RNA #RNA Therapeutics #saRNA

Ractigen Therapeutics closes over $31 million financing 

Ractigen Therapeutics, a clinical-stage biotechnology company pioneering small activating RNA (saRNA) therapeutics and advanced extrahepatic delivery systems, has closed a new financing round exceeding $31 million (over RMB 200 million).  The round was led by Guozhong Capital, with participation from IDG Capital, China Everbright Limited, Jolmo Capital, Win-Win Capital, and SND Financial… Read More

#News

#Drug development #Drug discovery #Obesity #RNA Therapeutics

New DDW Highlights podcast: 2 June 2025

The latest episode of the DDW Highlights podcast is now available to listen to below. DDW’s Megan Thomas narrates five key stories of the week to keep DDW subscribers up-to-date on the latest industry updates. News stories of note for this week include a major deal signed between Eli… Read More

#News

RNA
#Drug development #Drug discovery #Obesity #RNA Therapeutics

This week in drug discovery (26-30 May)

News round-up for 26-30 May by DDW Editor Reece Armstrong. News stories of note for this week include a major deal signed between Eli Lilly and Rznomics in the field of RNA-editing therapies, and a potential quality-of-life breakthrough for patients with Parkinson’s. Lilly and Rznomics agree $1.3 billion… Read More

#News

Lipid nanoparticle mRNA vaccine
#Drug delivery #Guide #Lipid based nanoparticle (LNP) #mRNA #RNA Therapeutics #siRNA

Lipid nanoparticle formulation: Download the Guide

A new Guide is now available for free download from Cayman Chemical entitled ‘Lipid Nanoparticle Formulation: Basic Concepts & Preparation Procedures‘. Lipid nanoparticles (LNPs) have great potential to revolutionise the development of nucleic acid therapies. Download the Guide to learn more about: The basic concepts and components… Read More

#News

#Drug delivery #Lipid based nanoparticle (LNP) #mRNA #RNA Therapeutics #siRNA

Lipid Nanoparticle Formulation: Basic Concepts & Preparation Procedures

Lipid nanoparticles (LNPs) have great potential to revolutionise the development of nucleic acid therapies. Download the Guide to learn more about: The basic concepts and components of lipid-based drug delivery systems Important considerations for LNP design, stability, and storage Techniques for LNP preparation, characterisation, and functional assessment… Read More

#Intelligence #Resources

RNA
#3D printing #BioNTech #Partnership #RNA Therapeutics #Triastek

BioNTech and Triastek team up to create 3D printed RNA therapeutics

BioNTech and Triastek have entered into a research collaboration and platform technology license agreement to develop RNA therapeutics for oral delivery based on 3D printing technology. The collaboration aims to provide groundbreaking therapies to address unmet medical needs in an easy to administer oral formulation. The partners plan to use… Read More

#Business & Investment #News

#Genomics #RNA biology #RNA Therapeutics #Serna Bio #Small molecules #Transcriptomics

The untapped potential of the transcriptome  

Serna Bio was founded by Rabia Khan, who is also the CEO, to unlock the transcriptome as a drug discovery target. DDW’s Megan Thomas speaks to Khan about the work her team is doing to create the first map of the druggable transcriptome, which involves understanding RNA biology to discover… Read More

#Exclusive Content #Opinion

RNA vaccine
#Drug discovery #mRNA #RNA Therapeutics #Vaccines

The evolution of the RNA therapeutics landscape 

Bruce Sullenger, PhD Founder and Scientific Advisor of Basking Biosciences, and Joseph W And Dorothy W Beard Distinguished Professor of Experimental Surgery and the Founding Director of the Translational Research Institute at Duke University, explores the rise of RNA therapeutics.   For decades, the life sciences community held the belief… Read More

#Exclusive Content